ClinicalTrials.gg
RecruitingNCT07715812A-3650-0001Updated Jul 20, 2026

E-diary vs Paper Diary in Binge Eating Disorder

An interventional study of The subject will complete e-diary for 2 weeks and complete paper diary for 2 weeks in Binge Eating Disorder, sponsored by Lindner Center of HOPE. Recruiting at 1 site in United States. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2026-07-20.

Sponsored by Lindner Center of HOPE · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
Up to 18 Years
Sex
All
01

Study summary

The purpose of this study is to examine how binge eating episodes are recorded using two different diary formats: a paper diary and an electronic diary and to see whether both formats collect information in the same way and to understand which of the two formats is easier to use

Read the detailed description

Binge eating (BE) diary has already been successfully employed to measure binge eating behavior in clinical trials. This has been implemented using a paper diary (p-diary) completed daily in the evening. From the diary records, binge eating episodes are confirmed by a healthcare professional. Despite the advantages of electronic implementation and the clinical and research need for such a tool, no electronic diary (e-diary) has been systematically tested in comparison to paper diary through an empirical study.

The following scientific questions are to be answered with this project

  1. Are the paper and electronic diary formats considered measurement comparable, such that data collected using the different formats across different studies or programs could be directly comparable?
  2. Are there differences in usability that might limit completion rates or lead to under reporting using one or the other mode of data collection?
02

Conditions studied

  • Binge Eating Disorder

Keywords

  • binge eating, diary
03

In context

Binge-Eating Disorder

233 studies on the registry are indexed under Binge-Eating Disorder; 53 are open to participants now.

This study's planned enrollment of 40 is below the median of 77 across 190 interventional studies indexed under Binge-Eating Disorder.

Browse Binge-Eating Disorder studies →

Lead sponsor

Lindner Center of HOPE is the lead sponsor of 26 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Diagnosis of Binge Eating Disorder based on The , Fifth Edition (DSM-5) (5) criteria (as assessed with BED module of the structural clinical interview [SCID] (6) for DSM-5)
  2. Reported frequency of minimum of 2 binge episodes/week
  3. Age: over 18 years of age
  4. Ability to understand and complete self-reporting measures 5 . The subject owns a smartphone compatible with Google Play or Apple App Store and is able to download and use apps appropriately.

Exclusion criteria

Exclusion Criteria:

  1. Comorbid psychiatric conditions requiring immediate hospitalization (as assessed with MSE)
  2. IInability to use smartphone or paper diary due to physical limitations or technical barriers (e.g., severe visual impairment)
  3. Inability to read/write in English
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Other
    paper diary arm

    subjects will complete paper diary for 2 weeks

    Other: complete paper diary for 2 weeks

  • Other
    e-diary arm

    subjects will complete e-diary for 2 weeks

    Other: The subject will complete e-diary for 2 weeks

Interventions

  • OtherThe subject will complete e-diary for 2 weeks

    The subject will complete one diary format and switch to the other after 2 weeks

  • Othercomplete paper diary for 2 weeks

    complete paper diary for 2 weeks

06

What researchers measure

Primary outcomes

  1. The primary endpoint is the comparison of number of binge eating episodes recorded over a 14-day period between diary formats

    The primary endpoint is the comparison of number of binge eating episodes recorded over a 14-day period between diary formats

    Time frame: from enrollment v1,day 0 to v3,day 30

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07715812
Lead sponsor
Lindner Center of HOPE
Collaborators
SignanthHealth, The Lindner Center of HOPE
Responsible party
Sponsor
First posted
Jul 20, 2026
Start date
Jul 30, 2026 (estimated)
Primary completion
Dec 30, 2027 (estimated)
Completion
Mar 30, 2028 (estimated)
Last update
Jul 20, 2026

Study contacts

Anna I Guerdjikova, PhD,LISW, PhD,LISW
Contact
anna.guerdjikova@lindnercenter.org
5135360700

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion